Trial Outcomes & Findings for The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic (NCT NCT02577146)

NCT ID: NCT02577146

Last Updated: 2019-12-10

Results Overview

Number of days that have elapsed from date of diagnosis to date of stone passage or intervention to maximum observation time (42 days).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

74 participants

Primary outcome timeframe

42 days

Results posted on

2019-12-10

Participant Flow

Participant milestones

Participant milestones
Measure
Study Ultrasound
Study ultrasound with ureteral jet assessment will be obtained after CT diagnosis of ureteral calculus is made. Ureteral jet data will be documented and patients will be followed prospectively for 42 days for spontaneous stone passage or need for surgical intervention. renal and bladder ultrasound with ureteral jet assessment: The number of jets from each ureteral orifice will be tabulated over time so that ureteral jet frequency, defined as number of jets per minute, can be calculated. Patients will be categorized into three groups. Group I- no ureteral jets on the symptomatic side; Group II- continuous low-level ureteral jet on the symptomatic side; Group III- ureteral jets similar to nonsymptomatic side.
Overall Study
STARTED
74
Overall Study
COMPLETED
46
Overall Study
NOT COMPLETED
28

Reasons for withdrawal

Reasons for withdrawal
Measure
Study Ultrasound
Study ultrasound with ureteral jet assessment will be obtained after CT diagnosis of ureteral calculus is made. Ureteral jet data will be documented and patients will be followed prospectively for 42 days for spontaneous stone passage or need for surgical intervention. renal and bladder ultrasound with ureteral jet assessment: The number of jets from each ureteral orifice will be tabulated over time so that ureteral jet frequency, defined as number of jets per minute, can be calculated. Patients will be categorized into three groups. Group I- no ureteral jets on the symptomatic side; Group II- continuous low-level ureteral jet on the symptomatic side; Group III- ureteral jets similar to nonsymptomatic side.
Overall Study
Lost to Follow-up
8
Overall Study
Physician Decision
3
Overall Study
Screen Failure
17

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Study Ultrasound
n=46 Participants
Study ultrasound with ureteral jet assessment will be obtained after CT diagnosis of ureteral calculus is made. Ureteral jet data will be documented and patients will be followed prospectively for 42 days for spontaneous stone passage or need for surgical intervention. renal and bladder ultrasound with ureteral jet assessment: The number of jets from each ureteral orifice will be tabulated over time so that ureteral jet frequency, defined as number of jets per minute, can be calculated. Patients will be categorized into three groups. Group I- no ureteral jets on the symptomatic side; Group II- continuous low-level ureteral jet on the symptomatic side; Group III- ureteral jets similar to nonsymptomatic side.
Age, Categorical
<=18 years
0 Participants
n=46 Participants
Age, Categorical
Between 18 and 65 years
43 Participants
n=46 Participants
Age, Categorical
>=65 years
3 Participants
n=46 Participants
Age, Continuous
45.1 years
STANDARD_DEVIATION 13.9 • n=46 Participants
Sex: Female, Male
Female
16 Participants
n=46 Participants
Sex: Female, Male
Male
30 Participants
n=46 Participants
Region of Enrollment
United States
46 Participants
n=46 Participants

PRIMARY outcome

Timeframe: 42 days

Population: 28 cases were not included in analysis due to screen failures, subject non-compliance and missing data.

Number of days that have elapsed from date of diagnosis to date of stone passage or intervention to maximum observation time (42 days).

Outcome measures

Outcome measures
Measure
Study Ultrasound
n=46 Participants
Study ultrasound with ureteral jet assessment will be obtained after CT diagnosis of ureteral calculus is made. Ureteral jet data will be documented and patients will be followed prospectively for 42 days for spontaneous stone passage or need for surgical intervention. renal and bladder ultrasound with ureteral jet assessment: The number of jets from each ureteral orifice will be tabulated over time so that ureteral jet frequency, defined as number of jets per minute, can be calculated. Patients will be categorized into three groups. Group I- no ureteral jets on the symptomatic side; Group II- continuous low-level ureteral jet on the symptomatic side; Group III- ureteral jets similar to nonsymptomatic side.
Time in Days From Diagnosis to Stone Passage.
Present Jets
5 Days
Interval 3.0 to 13.0
Time in Days From Diagnosis to Stone Passage.
Absent Jets
13 Days
Interval 8.0 to
Sample size is too small to estimate upper limit of 95% confidence interval.

SECONDARY outcome

Timeframe: 42 days

Population: 28 cases were not included in analysis due to screen failures, subject non-compliance and missing data.

Outcome measures

Outcome measures
Measure
Study Ultrasound
n=46 Participants
Study ultrasound with ureteral jet assessment will be obtained after CT diagnosis of ureteral calculus is made. Ureteral jet data will be documented and patients will be followed prospectively for 42 days for spontaneous stone passage or need for surgical intervention. renal and bladder ultrasound with ureteral jet assessment: The number of jets from each ureteral orifice will be tabulated over time so that ureteral jet frequency, defined as number of jets per minute, can be calculated. Patients will be categorized into three groups. Group I- no ureteral jets on the symptomatic side; Group II- continuous low-level ureteral jet on the symptomatic side; Group III- ureteral jets similar to nonsymptomatic side.
The Number of Cases With Concordant Treatment Recommendations Based on the Ultrasound and CT Scan.
29 Cases

Adverse Events

Study Ultrasound

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alana Desai, M.D.

Washington University School of Medicine

Phone: (314) 362-7581

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place